In the present study phytochemical investigation of the methanol extract of the stem bark of Horsfieldia superba led to the isolation of twenty compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , of which three (1-3) were new. However, compounds 2 and 3 were previously reported as synthetic α,β-lactones. The compounds were characterized as (-)-3,4′,7-trihydroxy-3′-methoxyflavan (1), (-)-5,6-dihydro-6-undecyl-2H-pyran-2-one (2) , and (-)-5,6-dihydro-6-tridecyl-2H-pyran-2-one (3) . Seventeen other known compounds were also isolated and identified as (-)-viridiflorol (4), hexacosanoic acid (5) , β-sitosterol (6) , methyl 2,4-dihydroxy-6-methylbenzoate (methylorsellinate) (7) , methyl 2,4-dihydroxy-3,6-dimethylbenzoate (8) , (-)-4′-hydroxy-7-methoxyflavan (9), (-)-4′,7-dihydroxyflavan (10), (-)-4′,7-dihydroxy-3′-methoxyflavan (11) , (+)-3,4′,7-trihydroxyflavan (12), (-)-catechin (13) , (-)-epicatechin (14) , (-)-7-hydroxy-3′,4′-methylenedioxyflavan (15) , 2′,3,4trihydroxy-4′-methoxydihydrochalcone (16) , 3′,4′,7-trihydroxyflavone (17) , (+)-4′-hydroxy-7-methoxyflavanone (18) , hexadecanoic acid (palmitic acid) (19) and 3,4-dihydroxybenzoic acid (20) . The structures of the compounds were fully characterized by various physical methods (melting point, optical rotation), spectral (UV, IR, ID and 2D NMR) and mass spectrometric techniques. In vitro assay of compounds 2 and 3 demonstrated moderate cytotoxic activities against human prostate (PC-3), colon (HCT-116) and breast (MCF-7) cancer cells, while the chloroform and ethyl acetate fractions of H. superba were found to exhibit moderate AChE inhibitory activity (IC 50 72 and 60 µg/mL).
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The genus Horsfieldia belongs to the Myristicaceae family and comprises about eighty species. These are mainly distributed in south-east Asia, Malaysia and New Guinea [1, 2] . Plants from this genus have been traditionally used for medicinal purposes in Southeast Asia [3] . The extract of H. majuscule was used as an antimicrobial agent in cosmetics and dermatological treatments. It was reportedly used as a natural preservative, as a deodorant, in treatment of scalp diseases, such as hyperseborrhea and acne, and as a dentifrice [4] . The methanol extracts of leaves, root and stem barks of H. helwigii showed a broad spectrum of antibacterial activity [5] . The barks and leaves of H. irya and H. glabra are used in Thailand as a popular medicine to treat intestinal infections, as well as a remedy for sore throats, sores and pimples [2, 6] . A literature survey revealed that a number of phytochemical studies on plants from this genus have been carried out, reporting the presence of numerous kinds of secondary metabolites, such as lignans [6, 7] , essential oil [8] , resorcinols, flavans [9] , chromones [2] and arylalkanones [7, 10] .
H. superba is a small tree distributed widely in Malaysia, Indonesia, and Singapore and has been used as a medicinal plant [3] . Previous phytochemical study on the leaves of this species revealed the presence of the oxindole alkaloid, horsfiline, 6-methoxy-2-methyl-1,2,3,4-tetrahydro-β-carboline and 5-methoxy-N-Ndimethyltryptamine [11] . However, to our knowledge there has not been any report on the bioactivity of the constituents isolated from this species. In this report we describe the isolation and characterization of three new compounds, a flavan (1) and alkyl α,β-lactones 2-3, along with seventeen known compounds (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . We further report the cytotoxic activity and acetylcholine esterase (AChE) inhibition evaluation of the isolates and fractions from H. superba.
The methanol extract of the dried stem bark of H. superba was initially fractionated from a water-methanol suspension into n-hexane, chloroform and ethyl acetate fractions. Subsequent purification of the fractions by repeated column chromatography and semipreparative HPLC led to the isolation of twenty pure compounds (1-20). Among these, compounds 1-3 ( Fig. 1 ) were found to be new, although, compounds 2 and 3 were previously reported as synthetic α,β-lactones. The structures of these compounds were established mainly on the basis of their mass spectrometric and 1 H NMR and 13 C NMR spectroscopic data. Assignments were facilitated by COSY, HMBC and HSQC experiments. , which supported the earlier assignment of the proton signals. The HMBC spectrum showed correlation between methoxyl protons at δ H 3.84 and C-3' (δ C 148.9), suggesting an attachment to C-3'. Further correlations were also observed between H-2' (6.97) and C-4' (147.6), as well as between H-6' (6.79) and C-4', which suggested that the hydroxyl group was attached to C-4' (Fig. 2 ). These assignments were further supported by EIMS, which exhibited mass fragments at m/z 166 (56%) for [M + -C 7 H 7 O 2 ] and 123 (34 %) for [M + -C 9 H 9 O 3 ], resulting from a retro Diels-Alder fragmentation. Thus, the hydroxyl and methoxyl groups were deduced to be on ring B, while another hydroxyl group was attached to ring A. NOE effects were observed on H-2 (δ H 4.66) and H-4β (δ H 2.90) when H-3 (δ H 4.04) was irradiated, indicating that H-2, H-3 and H-4β are on the same side of the molecule (Fig. 2 ). Thus, 1 was determined to have a cis-configuration by NOE correlations.. The aromatic proton H-2' (δ H 6.97) was also observed when the methoxyl protons (δ H 3.84) were irradiated, proving the C-3' position of the methoxyl group to be on ring B. Based on these observations, the structure of 1 was concluded to be (-)-3,4′,7trihydroxy-3′-methoxyflavan, which is new.
Compound 2 was isolated as white amorphous solid. The HRESI-MS exhibited a molecular ion peak at m/z 253.21442 [M+H] + (calcd 253.2162), which corresponded to the molecular formula C 16 H 28 O 2 with three double bond equivalents. The 1 H NMR spectrum exhibited two signals for an α,β-unsaturated lactone at δ H 6.88 (m, H-4) and 6.03 (d, J = 11.5 Hz, H-3), and one multiplet oxymethine at 4.42 (m, H-6), as well as proton signals belonging to C-5 methylene at δ H 2.34 (2H, m, H-5). Eight other long chain methylene groups at δ H 1.84-1.77, and a terminal methyl group at δ H 0.90 were also observed. The 13 C NMR spectrum displayed a quaternary carbon signal of the carbonyl lactone at δ C 164.8 and an oxygenated sp 3 carbon at δ C 78.3. The resonances at δ C 145.2 and 121.9 were typical chemical shifts for an α,β-unsaturated lactone. Other resonances in the upfield region were assignable to long side chain carbons.
The α,β-unsaturated lactone system in the molecule was further supported by the H-H COSY spectrum, which showed correlations between H-4, H-3 and H-5, and between H-6 and H-5. The HMBC spectrum ( Fig. 3 ) further revealed correlations between both H-4 (δ H 6.88) and H-3 (δ H 6.03) with C-2 (δ C 164.8) and C-5 (δ C 29.8), as well as correlations between H-6 (δ H 4.42) and C-5, all of which provided further evidence for the α,β-unsaturated lactone system. Finally, HMBC correlation observed between the methine proton at δ H 4.42 (H-6) to the carbon signal at δ C 34.1 (C-1′) confirmed the connectivity on the side chain at the C-6 position. The mass spectrum of compound 2 was similar to that of 5,6-dihydro-6pentyl-2H-pyran-2-one, with major ions at m/z 97 (base peak) and 68 [12] . On the basis of this evidence, compound 2 was concluded to be (-)-5,6-dihydro-6-undecyl-2H-pyran-2-one. Compound 3 was isolated as white amorphous solid with a mp of 44-46 o C. The HRESI-MS showed a molecular ion [M+H] + peak at m/z 281.2457 (calcd. 281.2475) suggesting that 3 has a molecular formula of C 18 H 32 O 2 , with three double bond equivalents. The 1 H and 13 C NMR spectra of compound 3 closely resembled those of compound 2 and the fragment ion at m/z 97 (base peak) in the mass spectrum indicated that this compound contained the same lactone moiety as compound 2. Based on the molecular ion mass data, compound 3 carried a side chain containing two methylene units higher than compound 2. Thus, the final structure of 3 was concluded as (-)-5,6-dihydro-6-tridecyl-2H-pyran-2-one. Compounds 2 and 3 have been reported previously as synthetic analogues [13] . The two compounds are herein reported for the first time as natural products.
Seventeen other compounds were also isolated from this species. These were (-)-viridiflorol [14] , hexacosanoic acid [15] , β-sitosterol [16] , methyl 2,4-dihydroxy-6-methylbenzoate (methylorsellinate) [17] , methyl 2,4-dihydroxy-3,6-dimethylbenzoate [18] , (-)-4′hydroxy-7-methoxyflavan [19] , (-)-4′,7-dihydroxyflavan [20] , (-)-4′,7-dihydroxy-3′-methoxyflavan [21] , (+)-3,4′,7-trihydroxyflavan (12) [22] , (-)-catechin, (-)-epicatechin [23] , (-)-7-hydroxy-3′,4′methylenedioxyflavan [24] , 2′,3,4-trihydroxy-4′-methoxydihydrochalcone [25] , 3′,4′,7-trihydroxyflavone [26] , (+)-4′-hydroxy-7methoxyflavanone [27] , palmitic acid (19) [28] and 3,4-dihydroxy-Secondary metabolites from Horsfieldia superba Natural Product Communications Vol. 8 (4) 2013 449 benzoic acid [29] . The identity of these compounds was confirmed by analysis of their spectral data, as well as by comparison of their physical properties with those reported in the literature.
The crude extracts and the isolated compounds were subjected to cytotoxicity assay. Only compounds 2 and 3 showed moderate growth inhibition potency against the tested cell lines, giving IC 50 values which were approximately five-fold weaker than the positive standard, doxorubicin. Compound 2 was slightly more active than 3 against all the cell lines for all the three response parameters. At GI 50 in MCF-7 cells, 2 was more potent than 3 by more than 2 fold. Except for compound 2 against HCT-116, both compounds 2 and 3 failed to show any significant cytotoxic effect (LC 50 ≥ 100 µM) against the cells tested. Moreover, both 2 and 3 did not show any tumor type selectivity ( Table 1 ).
The crude fractions and isolated compounds from Horsfieldia superba were also tested for inhibitory activity against acetylcholinestrerase (AChE). Initially, the chloroform and ethyl acetate fractions of H. superba demonstrated moderate enzyme inhibition (IC 50 72 and 60 µg/mL, respectively). Following this, all the isolated compounds from H. superba were tested for acetylcholinesterase inhibition in a TLC bioautographic examination. Only compounds 2, 3, viridiflorol and (-)-4′-hydroxy-7-methoxyflavan showed positive enzyme inhibition activity. However, upon repeating the test using a microplate assay, the four compounds were found to be inactive, giving IC 50 values > 100 µM. Similar false positive results resulting from TLC bioautographic assay have also been reported previously [30] 
Extraction and isolation:
The dried stem bark of H. superba (8 kg) was ground and extracted with MeOH (100%) 3 times at room temperature, and about 120 g of residue was obtained after evaporating the solvent in vacuo. The crude MeOH extract (120 g) was suspended in distilled water and the suspension was sequentially partitioned with n-hexane, chloroform (CHCl 3 ), ethyl acetate (EtOAc) and n-BuOH to give n-hexane (11.6 g), CHCl 3 (6.2 g), EtOAc (9.5 g) and n-BuOH (34.2 g) soluble fractions.
The crude n-hexane fraction (9 g) was chromatographed on a silica gel column and eluted with n-hexane-EtOAc (1:0 Subfraction H 3/3 (887 mg) was applied to a silica gel column and eluted using a gradient solvent system of n-hexane-EtOAc (1:0-0:1) to give 4 further subfractions (H 3/3/1 -H 3/3/4 ). Subfraction H 3/3/3 (60 mg) was rechromatographed on silica gel and eluted with n-hexane-EtOAc to give β-sitosterol (10 mg). Subfraction H 3/3/4 (254 mg) was subjected to reverse-phase silica gel CC and eluted with H 2 O-MeOH (1:4, 0:1) to afford (-)-4′-hydroxy-7-methoxyflavan (58 mg). Fraction H 4 was passed through a Sephadex LH-20 column (CHCl 3 -MeOH, 50:50) to afford 3 fractions (H 4/1 -H 4/3 ). Subfraction H 4/2 (210 mg) was rechromatographed over silica gel (n-hexane-EtOAc, 1:0, 4:1, 1:1 and 0:1) to give palmitic acid (15 mg).
The CHCl 3 fraction (5.0 g) was subjected to silica gel CC (230-400 mesh, 120 g) eluted with n-hexane-EtOAc to yield 32 fractions, which were recombined based on their TLC pattern into 8 subfractions (C 1 -C 8 ). Subfraction C 2 (194 mg) was passed through a Sephadex LH-20 column with CHCl 3 -MeOH (1:1) as eluent and then submitted to preparative reverse-phase HPLC to give 6 pure compounds, methyl 2,4-dihydroxy-6-methylbenzoate (2 mg, t R 8.6), methyl 2,4-dihydroxy-3,6-dimethylbenzoate (3 mg, t R 12.2), (-)-7hydroxy-3′,4′-methylenedioxyflavan (10 mg, t R 15.0), (-)-4′hydroxy-7-methoxyflavan (70 mg, t R 16.9), (-)-6-undecyl-5,6dihydro-2H-pyran-2-one (6 mg, t R 31.6), and (-)-6-tridecyl-5,6dihydro-2H-pyran-2-one (9 mg, t R 34.4). Fraction C 3 (192 mg) was fractionated using a Sephadex LH-20 column with CHCl 3 -MeOH (1:1) as eluent to provide 5 fractions (C 3/1 -C 3/5 ). Fraction C 3/5 (90 mg) was rechromatographed over silica gel, eluted with n-hexane-450 Natural Product Communications Vol. 8 (4) 2013
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EtOAc (4:1, 3:2, 1:1, 0:1) to furnish 3 subfractions (C 3/5/1 -C 3/5/3 ). Subfraction C 3/5/2 (39 mg) was separated by preparative reversephase HPLC to give 3 compounds, (-)-7,4′-dihydroxyflavan (3 mg, t R 24.20), (-)-4′,7-dihydroxy-3′-methoxyflavan (11 mg, t R 25.45), and (-)-4′-hydroxy-7-methoxyflavanone (2 mg, t R 30.96).
The EtOAc fraction (9.0 g) was subjected to silica gel CC eluting with a gradient of n-hexane-EtOAc (1:0, 4:1, 3:2, 1:1, 0:1) and then EtOAc-MeOH (4:1, 1:1 and 0:1) to afford 64 fractions, which were recombined into 11 major fractions (E 1 -E 11 ) based on their TLC pattern. Fraction E 4 (107 mg) was subjected to further CC, initially over Sephadex LH-20 (CHCl 3 -MeOH, 7:3) and then over silica gel (n-hexane-acetone, 3:2) to yield (-)-4′,7-dihydroxyflavan (13 mg). Fraction E 8 (488 mg) was subjected to reverse-phase CC, eluting with a stepped gradient solvent system of H 2 O: MeOH (90:10 to 0:100), to afford 3 major fractions (E 8/1 -E 8/3 ). Subfraction E 8/1 (170 mg) was rechromatographed by preparative reversed phase HPLC using a gradient mobile phase consisting of H 2 O: CH 3 CN (5-100%, over 45 min) to give 3,4-dihydroxybenzoic acid (17 mg, 18 .74 t R ), 3,4',7-trihydroxyflavan (5 mg, t R 33.25) and (-)-3,4′,7-trihydroxy-3′-methoxyflavan (3 mg, t R 34.25) . Subfraction E 8/2 (149 mg) was also subjected to preparative reversed phase HPLC with a gradient mobile phase consisting of H 2 O: CH 3 CN (5-100%, over 45 min) to give (+)-2, 3′,4′-trihydroxy-4-methoxychalcone (11 mg, t R 22.49) and 3′,4′,7-trihydroxyflavone (4 mg, t R 25.95). Fraction E 9 (1.5 g) was passed over a Sephadex LH-20 column with CHCl 3 -MeOH (1:1) as eluent to afford 5 subfractions (E 9/1 -E 9/5 ). Subfraction E 9/5 (0.5 g) was subjected to chromatography over a silica gel column, eluting with CHCl 3 -MeOH (1:0, 9:1, 8:2, 7:3, 1:1, 0:1) to afford 3 subfractions (E 9/5/1 -E 9/5/3 ). Subfraction E 9/5/2 was purified by preparative reversed phase HPLC (H 2 O: MeOH, 5-100%, over 45 min) to yield (-)-catechin (3 mg, t R 21.77) and (-)-epicatechin (85 mg, t R 25.97).
Cytotoxicity assay:
In-vitro cytotoxic activity against MCF-7, HCT-116 and PC-3 cells was determined using the MTT method for cell viability, as previously described [32] Antiacetylcholinesterase assays: The TLC bioautographic method, as described by Marston et al [33] , was used for detecting acetylcholinesterase inhibitors in the crude fractions and the isolated compounds. The 96-well microplate (Ellman's assay) [34] was used to determine the in vitro anticholinesterase activities of crude fractions and pure compounds . Acetylcholinesterase from electric eel (type VI-s, 2KU; Code: C2888; Sigma: 1.53 mg solid, 58 U/mg solid, 1210 U/mg protein) was dissolved in 100 µL phosphate buffer (pH 7.4) to make the enzyme stock solution. This was followed by diluting 10 µL of stock enzyme solution with phosphate buffer (pH 7.4) to obtain 0.5 U/mL enzymes. Ellman's reagent, 5,5-dithiobis-2-nitrobenzoic acid (DTNB; Code: D218200; Sigma), was prepared to the final concentration of 0.15 mM by dissolving 7.61 mg DTNB in100 mL phosphate buffer (pH 7.4). Acetylcholine iodide (ATCI) (9.76 mg) (Code: A5751; Sigma) was dissolved in 10 mL H 2 O to make the substrate final concentration of 0.15 mM. Tacrine was used as the positive control stock solution (10 mM) in the assay [34] . The crude fractions and pure compounds were dissolved in DMSO to obtain 4 concentrations (1000 µM, 100 µL, 10 µL and 1 µL). The DTNB solution (210 µL) was added to every well. The samples (20 µL) were subsequently added in triplicate and tacrine (20 µL) was then placed in the control wells and finally the enzyme solution (20 µl) was added to each well. The mixture was kept for 10 min, and then substrate reagent (20 µL) was added. The rate of yellow anion production was measured at the absorbance of 412 nm using a 96-well microplate reader 
